Autopsy report · NCT03852979

Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility

“study is merged with CONTESSA study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 1 year 2 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

The Netherlands Cancer Institute

Sponsor type

University, hospital or other

Conditions

Cervical Cancer

Interventions

Paclitaxel; Carboplatin; conisation

Participants

1

Sites

1

Countries

Netherlands

Trials that died the same way

• Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
  “study merged with another study” (75% match in meaning)
• Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
  “The study was incorporated in another study.” (65% match in meaning)
• Use of NAVA in Intubated Preterm
  “Another institution performed the study” (64% match in meaning)
• Fracture and Neurological Injury
  “A new version of the study will be submitted” (60% match in meaning)
• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.